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Development of malaria parasites within vertebrate
erythrocytes requires nutrient uptake at the host cell
membrane. The plasmodial surface anion channel
(PSAC) mediates this transport and is an antimalarial
target, but its molecular basis is unknown. We report
a parasite gene family responsible for PSAC activity.
Weusedhigh-throughputscreening fornutrientuptake
inhibitors to identify a compound highly specific for
channels from the Dd2 line of the human pathogen
P. falciparum. Inheritance of this compound’s affinity
in aDd23HB3genetic crossmaps to a single parasite
locus on chromosome 3. DNA transfection and in vitro
selections indicate thatPSAC-inhibitor interactionsare
encoded by two clag3 genes previously assumed to
function incytoadherence. Thesegenesareconserved
in plasmodia, exhibit expression switching, and en-
codean integral protein on thehostmembrane, aspre-
dicted by functional studies. This protein increases
host cell permeability to diverse solutes.INTRODUCTION
Successful intracellular development of malaria parasites
depends on directed remodeling of the host erythrocyte cytosol
and plasma membrane. For example, P. falciparum and all
studied malaria parasites increase erythrocyte permeability to
numerous solutes including nutrients required for intracellular
parasite growth. Sugars, amino acids, purines, vitamins, and
the cation choline are needed for in vitro propagation and have
increased permeability after infection (Homewood and Neame,
1974; Ginsburg et al., 1985; Upston and Gero, 1995; Saliba
et al., 1998; Staines et al., 2000). Anions and antimalarial toxins
also have increased uptake (Kirk et al., 1994; Hill et al., 2007;
Lisk et al., 2008). Intriguingly, the parasite neverthelessmaintains
a low Na+ permeability at the host membrane to avoid osmotic
lysis in the bloodstream (Cohn et al., 2003).New antimalarial drugs are desperately needed. Conservation
of erythrocyte permeability changes in divergent malaria para-
sites suggests that the responsiblemechanismmay be a suitable
drug target (Lisk and Desai, 2005). Interest has been further
increased by the recognition that the parasite can alter the
permeability to acquire resistance to antimalarials (Hill et al.,
2007; Lisk et al., 2008).
Despite its central role in parasite biology and therapeutic
potential, the origin and precise nature of the uptake mechanism
have been controversial. Electrophysiological studies over the
past decade have implicated transmembrane transport through
one or more ion channels on the erythrocyte surface (Desai
et al., 2000; Staines et al., 2007). Although there is agreement
that these channels are anion selective and that they appear on
the hostmembrane somehours after parasite invasion, the genes
responsible for each proposed ion channel remain unknown.
Some studies have proposed activation of quiescent human
channels intrinsic to the erythrocyte (Decherf et al., 2004; Duran-
tonet al., 2004;Verlooet al., 2004),whereasothers support oneor
more parasite-encoded proteins trafficked to the host
membrane. The plasmodial surface anion channel (PSAC) is the
primary candidate for a parasite-encoded ion channel (Alkhalil
et al., 2004), but computational analyses of completed parasite
genomeshavenot revealedorthologsof classical anionchannels.
We have now used a genetic approach to identify a parasite
gene family involved in PSAC activity. Our studies combine
high-throughput screens for novel channel inhibitors, electro-
physiology revealing direct action on PSAC, linkage analysis in
a P. falciparum genetic cross, DNA transfection experiments, in-
vitro selections, and mutant analysis to demonstrate the role of
two paralogous genes in PSAC activity. We propose that these
genes contribute to a novel microbial ion channel for the uptake
of diverse nutrient solutes.
RESULTS
High-Throughput Screen Identifies Isolate-Specific
Inhibitors
We searched for small-molecule inhibitors with differing effica-
cies against channels induced by divergent parasite lines. SuchCell 145, 665–677, May 27, 2011 ª2011 Elsevier Inc. 665
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Figure 1. High-Throughput Screen and a Dd2-Specific Inhibitor
(A) All-points histogram of mean % block at 2 hr for 48,157 compounds screened against sorbitol uptake by red blood cells infected with HB3 or Dd2 lines,
calculated according to Equation 2. Red shading reflects compounds having % blockR50, corresponding to inhibitory K0.5 values%1 mM (Pillai et al., 2010).
(B) All-points histogram of the normalized statistic WDS for these compounds (Equation 3). Most compounds have WDS <1.0, indicating negligible difference in
activity against channels on HB3 and Dd2.
(C) Structure of ISPA-28, a Dd2-specific inhibitor (WDS = 5.6; see also Figure S1).
(D) Continuous recordings of osmotic lysis kinetics in sorbitol for indicated parasites without or with 7 mM ISPA-28 (black and red traces, respectively).
(E) Dose responses for inhibition of organic solute permeability (P) into HB3- and Dd2-infected cells (circles and triangles, respectively). Symbols represent the
mean ± standard error of the mean (SEM) of up to eight measurements each. Solid lines represent best fits to Equation 1.inhibitors presumably bind to one or more variable sites on the
channel, whichmay result either frompolymorphisms in a parasite
channel gene or from differing activation of human channels.
To find these inhibitors, we used a transmittance-based assay
that tracksosmotic lysis of infectedcells in sorbitol, a sugar alcohol
with increased permeability after infection (Wagner et al., 2003).
This assay has previously been adapted to 384-well format and
used to find high-affinity PSAC inhibitors (Pillai et al., 2010).
Here,weused this format toscreena libraryof compoundsagainst
erythrocytes infectedwith theHB3 andDd2P. falciparum lines. To
maximize detection of hits, we chose a low stringency in our
screens by using library compounds at a high concentration666 Cell 145, 665–677, May 27, 2011 ª2011 Elsevier Inc.(10 mM) and by reading each microplate at multiple time points
(Pillai et al., 2010). Figure 1A tallies the all-points histogram for
compound activity averaged from screens of both lines. Eight
percent of compounds met or exceeded the threshold of 50%
normalized block at 2 hr (Equation 2), consistent with a low
screening stringency. We then defined a weighted difference
statistic (WDS, Equation 3) that normalizes measured differences
inefficacyagainstHB3andDd2channels to thestandarddeviation
ofpositivecontrolwells ineachmicroplate. Anall-pointshistogram
of this parameter revealed that 86% of all compounds produced
indistinguishable effects on the two parasite lines (WDS % 1.0,
Figure 1B). Thus, most inhibitor-binding sites are conserved.
Nevertheless, a small number of compounds produced signif-
icantly differing activities in the two screens. One such inhibitor,
named ISPA-28 (for isolate-specific PSAC antagonist based on
studies described below, Figure 1C), was reproducibly more
effective at inhibiting sorbitol uptake by Dd2- than by HB3-
infected cells. Secondary studies with ISPA-28 revealed an
800-fold difference in half-maximal affinities (Figures 1D and
1E) (K0.5 values of 56 ± 5 nM versus 43 ± 2 mM for Dd2 and
HB3, respectively; p < 1010).
We also examined ISPA-28 effects on uptake of the amino
acids alanine and proline as well as the organic cation phenyl-
trimethylammonium (PhTMA), solutes with known increases in
permeability after infection (Ginsburg et al., 1985; Bokhari
et al., 2008). Each solute’s permeability was inhibited with
dose responses matching those for sorbitol (Figure 1E), pro-
viding strong evidence for a single shared transport mechanism
used by these diverse solutes.
We next tested 22 different laboratory parasite lines and found
significant transport inhibition with only Dd2 and W2 (Figure S1
available online). Because Dd2 was generated by prolonged
drug selections starting with W2 (Wellems et al., 1988), their
channels’ distinctive ISPA-28 affinities suggest a stable heritable
element in the parasite genome.
ISPA-28 Interacts Directly with PSAC
To explore the mechanism of ISPA-28 block, we performed
patch-clamp of infected erythrocytes. Using the whole-cell
configuration, we observed similar currents on HB3- and Dd2-
infected cells in experiments without known inhibitors (Figures
2A and 2B). These currents exhibited inward rectification.
Previous studies have determined that they are carried primarily
by anions with a permeability rank order of SCN > I >Br > Cl
(Desai et al., 2000). ISPA-28 reduced their magnitudes but had
a significantly greater effect on Dd2-infected cells (p < 109,
n = 22–28 cells each). In the cell-attached configuration with
1.1MCl as the charge carrier, ion channel activity characteristic
of PSACwas detected on both lines (20 pS slope conductance
with fast flickering gating) (Alkhalil et al., 2004); without inhibitor,
channels from the two lines were indistinguishable (Figure 2C).
However, recordings with 10 mM ISPA-28 revealed a marked
difference as Dd2 channels were near-fully inhibited whereas
HB3 channels were largely unaffected (Figures 2D and 2F) (n =
6–7 channel molecules each; p < 0.0002). Thus, this compound’s
effects on single PSAC recordings parallel those on uptake of
sorbitol and other organic solutes.
We analyzed closed durations from extended recordings and
determined that ISPA-28 imposes a distinct population of long
block events, but only in recordings on Dd2-infected cells (Fig-
ure S2). At the same time, intrinsic channel closings, which occur
in the absence of inhibitor, were conserved on both parasites
and were not affected by ISPA-28 (events of < 20 ms duration
in Figure S2).
Inheritance of ISPA-28 Efficacy in a Dd2 3 HB3 Genetic
Cross
Wenext examined ISPA-28 efficacy against PSAC activity on red
blood cells infected with recombinant progeny clones from the
Dd23 HB3 genetic cross (Wellems et al., 1990). For each clone,we examined sorbitol uptake in the absence and presence of
7 mM ISPA-28, a concentration that optimally distinguishes the
parental channel phenotypes, and quantified inhibition (Equation
2). Although a few of the 34 independent progeny clones ex-
hibited intermediate channel inhibition, most resembled one
or the other parent (Figure 3A). Quantitative trait locus (QTL)
analysis was used to search for associations between ISPA-28
efficacy and inheritance of available microsatellite markers. A
primary scan identified a single significant peak having a loga-
rithm of odds (LOD) score of 12.6 at the proximal end of chromo-
some 3 (Figure 3B). A secondary scan for residual effects did not
find additional peaks reaching statistical significance (Figure S3).
The mapped locus contains 42 predicted genes (Table S1).
Although none have homology to classical ion channels from
other organisms, many are conserved in other plasmodia, as ex-
pected for the responsible gene(s) from conservation of PSAC
activity in malaria parasites (Lisk and Desai, 2005). The mapped
region is enriched in genes encoding proteins destined for export
to host cytosol (p < 104 by simulation), as typical of apicom-
plexan subtelomeric regions. Some of the encoded proteins
have one or more predicted transmembrane domains as usually
involved in channel pore formation, but this criterion may miss
some transport proteins. The PEXEL motif, which directs para-
site proteins to the host cell (Marti et al., 2004), was present in
some genes, but this module is not universally required for
export (Spielmann and Gilberger, 2010). Thus, computational
analyses suggested several candidates but could not specifi-
cally implicate any as ion channel components.
piggyBac-Mediated Complementations Implicate
Two Genes
We therefore selected a DNA transfection approach and chose
piggyBac transposase to complement Dd2 parasites with the
HB3 allele of individual candidate genes (Balu et al., 2005).
This method has the disadvantage that successfully transfected
parasites will carry both parental alleles and therefore be mero-
diploid for candidate genes. Nevertheless, we reasoned that the
marked difference in ISPA-28 efficacy between the parental lines
should produce a detectable change in transport phenotype
upon complementation with the responsible gene. Importantly,
the high efficiency of random integration conferred by piggyBac
permits rapid examination of many genes (Balu et al., 2009).
We cloned 14 genes with their endogenous 50 and 30 untrans-
lated regions (UTRs) from the HB3 parent into the pXL-BacII-
DHFR plasmid; a 15th construct containing a conserved but
not annotated open reading frame (ORF 147 kb) was also
prepared. Each was transfected individually along with a helper
plasmid encoding the transposase intoDd2parasites (Figure 4A).
Selection for hDHFR expression yielded parasites that stably
carry both Dd2 and HB3 alleles for each candidate. Because
an altered channel phenotype presumably requires expression
of the HB3 allele, we used reverse transcriptase PCR to amplify
polymorphic regions of each gene and sequenced the amplicons
to determine whether both parental alleles were transcribed; this
approach confirmed expression of 12 candidates (Figure 4B,
asterisks). We then performed ISPA-28 dose responses for inhi-
bition of sorbitol uptake by erythrocytes infectedwith each trans-
fectant (Figures 4B and 4C). Two transfectants, expressing HB3Cell 145, 665–677, May 27, 2011 ª2011 Elsevier Inc. 667
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Figure 2. ISPA-28 Interacts Directly with PSAC to Block Transport
(A) Whole-cell patch-clamp recordings on erythrocytes infected with indicated parasite lines without or with addition of 10 mM ISPA-28 to bath and pipette
solutions. Ensemble traces represent responses to pulses of100 to +100 mV (10 mV increments). Horizontal and vertical scale bars represent 20 ms and 5 nA,
respectively.
(B) Current-voltage relationships showing mean ± SEM whole-cell currents determined from up to 28 cells each. **p < 109.
(C) Single PSAC recordings on HB3- or Dd2-infected erythrocytes without inhibitor (left and right columns, respectively).
(D) Single-channel recordings from these lines with 10 mM ISPA-28 in bath and pipette solutions.
(E) Resolved intrinsic gating in the presence of ISPA-28, expanded from the bottom traces in (D) as indicatedwith red dashes. Black dashes adjacent to each trace
represent the closed channel level. Horizontal scale bar = 100ms, 2 s, or 74ms (panels C, D, and E, respectively); vertical scale bar = 3 pA for all panels. All whole-
cell and cell-attached recordings used symmetric bath and pipette solutions of 1Mcholine chloride, 115mMNaCl, 10mMMgCl2, 5mMCaCl2, 20mMNa-HEPES
(pH 7.4).
(F) Mean ± SEM single-channel open probability for indicated lines in the absence or presence of 10 mM ISPA-28. **p < 0.0002.
See also Figure S2.alleles for PFC0110w and PFC0120w, produced significant
changes in ISPA-28 efficacy with K0.5 values between those of
Dd2 and HB3, as expected for cells carrying channels from
both parental lines (p = 0.01 and p < 107 in comparison to
Dd2, respectively). Limiting dilution cloning of the PFC0120w668 Cell 145, 665–677, May 27, 2011 ª2011 Elsevier Inc.transfectant yielded a clone, Dd2-pB120w, that had undergone
at least one integration event (Figure S4); its ISPA-28 K0.5 was
indistinguishable from the transfection pool (not shown). For
both genes, quantitative analyses suggest relatively low-level
expression of the HB3 allele because the transfectantK0.5 values
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Figure 3. Inheritance of ISPA-28 Affinity in
a Genetic Cross and QTL Analysis
(A) Mean ± SEM block of sorbitol uptake by 7 mM
ISPA-28 for indicated parental lines and pro-
geny clones at a 60 min time point according to
Equation 2.
(B) Logarithm of odds (LOD) scores from a primary
scan of QTL associated with ISPA-28 efficacy. The
peak (LOD of 12.6) maps to the 50 end of chro-
mosome 3. Dashed line is the 0.05 significance
threshold calculated from 1000 permutations.
See also Figure S3.(95 ± 8 and 140 ± 12 nM) are closer to those of Dd2 than of HB3.
Expression levels of the two parental alleles may be influenced
by the genomic environment of the integration site, relative
promoter efficiencies, and a gene-silencing mechanism exam-
ined below.
Allelic Exchange Confirms a Role for These Genes
PFC0120w and PFC0110w are members of the clag multigene
family conserved in P. falciparum and all examined plasmodia;
the family’s name is based on proposed roles as cytoadher-
ence-linked antigens. These paralogs are known as clag3.1
and clag3.2, respectively, based on their locations on chromo-
some 3; P. falciparum carries three additional paralogs on chro-
mosomes 2, 8, and 9.
To examine the unexpected possibility that clag3 products
contribute to PSAC activity, we used an allelic exchange strategy
designed to transfer potent ISPA-28 block from the Dd2 line to
HB3 parasites. Because Dd2 parasites express clag3.1 but not
clag3.2 (Kaneko et al., 2005; see also next section), their
clag3.1 gene presumably encodes high ISPA-28 affinity. We
therefore constructed a transfection plasmid carrying a 3.2 kb
fragment from the 30 end of the Dd2 clag3.1 allele, an in-frame
C-terminal FLAG tag followed by a stop codon, and the fragment
gene’s 30 UTR (pHD22Y-120w-flag-PG1, Figure 5A). Because
this plasmid carries only a gene fragment and lacks a leaderCell 145, 665–sequence to drive expression, an altered
transport phenotype requires recombina-
tion into the parasite genome. We trans-
fected HB3 with this plasmid and used
PCR to screen for integration into each
of the five endogenous clag genes. This
approach detected recombination into
the HB3 clag3.2 gene; limiting dilution
cloning yielded HB33rec, a clone carrying
a single site integration event without
residual episomal plasmid (Figures S5A
and S5B). DNA sequencing indicated
recombination between single-nucleotide
polymorphisms at 3718 and 4011 bp from
the HB3 clag3.2 start codon. This recom-
bination site corresponds to successful
transfer of downstream polymorphisms
including a recognized hypervariable
region at 4266–4415 bp; contaminationwith other laboratory parasite lines was excluded by finger-
printing (Figure S5C).
PSAC activity on HB33rec exhibited a marked increase in
ISPA-28 efficacy (Figure 5B), further supporting a role for clag3
genes in sorbitol and nutrient uptake. Although this allelic
exchange strategy yielded a gene replacement in contrast to
the complementations achieved with piggyBac, the channel’s
ISPA-28 affinity was again intermediate between those of HB3
and Dd2 (Figure 5C). Several mechanisms may contribute to
the quantitatively incomplete transfer of inhibitor affinity. First,
two or more polymorphic sites on the protein might contribute
to ISPA-28 binding. If some of these sites are upstream from
the recombination event, the resulting chimeric protein may
have functional properties distinct from those of either parental
line. Second, the channel may contain additional unidentified
subunits; here, transfection to replace each contributing HB3
gene with Dd2 alleles might be required to match the ISPA-28
affinity of Dd2. Finally, in addition to the chimeric clag3.2HB3-
3.1Dd2 gene produced by transfection, HB3
3rec also carries the
clag3.1 gene endogenous to HB3 parasites. Expression of both
paralogs could also produce an intermediate ISPA-28 affinity.
To explore these possibilities, we performed cell-attached
patch-clamp on HB33rec-infected cells. Individual channel mole-
cules exhibiting ISPA-28 potencies matching those of each
parental line were identified (Figures S5D–S5F). These677, May 27, 2011 ª2011 Elsevier Inc. 669
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Figure 4. Complementation Implicates Two clag
Genes
(A) Schematic shows the plasmid maps for the translocon
vector into which genes from the HB3 line were cloned
(left) and the helper plasmid (right). See also Figure S4 and
Table S2.
(B) Mean ± SEM. ISPA-28 K0.5 values for Dd2 without or
after complementation with the indicated genes from
HB3. * indicates confirmed expression of the HB3 allele in
the transfectant.
(C) Osmotic lysis kinetics showing significant decrease
in ISPA-28 efficacy after transfection with PFC0120w.
[ISPA-28] in micromolar as indicated.recordings exclude scenarios that require a homogenous popu-
lation of channels with intermediate ISPA-28 affinity but are
consistent with several other mechanisms.
clag3 Gene Silencing and Switched Expression
Determine Inhibitor Affinity
In addition to the complex behavior of HB33rec, we noticed that
certain progeny from the genetic cross had lower ISPA-28670 Cell 145, 665–677, May 27, 2011 ª2011 Elsevier Inc.affinity than Dd2 despite inheriting the mapped
chromosome 3 locus fully from the Dd2 parent
(notably 7C20, 7C12, and CH361 in Figure 3A
and dose responses in Figure 6A). Because sub-
telomeric multigene families in P. falciparum are
susceptible to recombination and frequent gene
conversion events (Freitas-Junior et al., 2000),
we sequenced both clag3 paralogs and neigh-
boring genomic DNA from 7C20 and Dd2 but
did not find DNA-level differences. We therefore
considered epigenetic mechanisms that may
influence ISPA-28 affinity. clag3.1 and clag3.2
have been reported to undergo mutually exclu-
sive expression (Corte´s et al., 2007). Monoallelic
expression and switching, also documented for
other gene families in P. falciparum (Chen et al.,
1998; Lavazec et al., 2007), allow individual
parasites to express a single member of a multi-
gene family. Daughter parasites resulting from
asexual reproduction continue exclusive ex-
pression of the same gene through incompletely
understood epigenetic mechanisms (Howitt
et al., 2009). After a few generations, some
daughters may switch to expression of another
member of the gene family, affording diversity
that contributes to immune evasion (Scherf
et al., 2008).
We performed reverse transcriptase PCR
and found that Dd2 expresses clag3.1 almost
exclusively whereas the three discordant
progeny express clag3.2 at measurable levels
(Figure 6B), suggesting epigenetic regulation.
We therefore applied selective pressure to
progeny cultures with osmotic lysis in sorbitol
solutions containing ISPA-28. Inclusion ofISPA-28 preferentially spares infected cells whose channels
have high inhibitor affinity: these cells incur less sorbitol
uptake and do not lyse (Figure 1D). These selections, applied
on multiple consecutive days, yielded marked reductions in
parasitemia. Surviving parasites exhibited improved ISPA-28
affinity quantitatively matching that of the Dd2 parent (Fig-
ure 6C). Identical selections applied to HB3 and three
progeny inheriting its chromosome 3 locus did not change
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Figure 5. Allelic Exchange Yields an Inter-
mediate Phenotype
(A) Schematic shows the integration plasmid (top)
and the result of single homologous recombination
between the plasmid’s Dd2 clag3.1 fragment and
genomic clag3.2 of HB3. See primer sequences in
Table S3.
(B) Sorbitol-induced osmotic lysis kinetics for the
allelic exchange clone HB33rec with indicated
[ISPA-28].
(C) Mean ± SEM ISPA-28 dose response for
HB33rec (circles). This dose response is interme-
diate between those of HB3 and Dd2 (top and
bottom solid lines, respectively; taken from fits in
Figure 1E).
See also Figure S5.ISPA-28 affinity (Figure 6D, n = 3–4 separate attempts each;
data for progeny clones QC13, SC01, and 7C421 not shown),
excluding effects of the selections on unrelated genomic
sites.
Real-time qPCR using primers specific for each of the 5 clag
genes revealed that selection with sorbitol and ISPA-28 repro-
ducibly increased clag3.1 expression while decreasing that of
clag3.2 in progeny inheriting the Dd2 locus (Figure 6E; expres-
sion ratios in Figure 6F). Selections applied to the parental HB3
line were without effect (Figure 6F), consistent with its
unchanged inhibitor affinity. Although these selections did not
alter relative expression of other paralogs (clag2, clag8, and
clag9), we cannot exclude their possible contributions to PSAC
activity.
Selections were also applied to HB33rec, which carries
a chimeric clag3.2HB3-3.1Dd2 transgene and the clag3.1 gene
native to HB3. In contrast to the lack of effect on the isogenic
HB3 line, these synchronizations increased the transfectant’s
ISPA-28 affinity to a K0.5 of 51 ± 9 nM, matching that of Dd2
channels (Figures 6D and 6G). This change in channel pheno-
type correlated with a near exclusive expression of the trans-Cell 145, 665–gene (Figure 6H, first time point), con-
firming that expression of HB3 clag3.1
by a subset of cells accounts for the
intermediate ISPA-28 affinity observed
in Figure 5E. These findings also delimit
the determinants of ISPA-28 binding to
polymorphic sites within the Dd2
clag3.1 gene fragment transferred to
HB33rec.
Expression switching in P. falciparum
multigene families occurs over several
generations and should lead to a drift in
population phenotype. After selection of
the chimeric gene in HB33rec, continued
in vitro propagation yielded a gradual
decay in ISPA-28 affinity that correlated
with decreasing transgene expression
(Figures 6G and 6H). As with other multi-
gene families (Lavazec et al., 2007),
several factors may affect the steady-state ISPA-28 affinity and relative expression levels for the
two clag3 genes upon continued culture without selective
pressure.
Reverse Selections with a Distinct ISPA
We next sought a PSAC inhibitor with reversed specificity for
the two Dd2 clag3 products. To this end, we surveyed hits
from our high-throughput screen using the progeny clone
7C20 before and after selection for clag3.1 expression. This
secondary screen identified ISPA-43 as a PSAC inhibitor with
an allele specificity opposite that of ISPA-28 (Figure 6I and Fig-
ure S6B, K0.5 of 32 and 3.9 mM for channels associated with
clag3.1 and clag3.2 genes from Dd2, respectively). We then
applied sorbitol synchronizations with 4 mM ISPA-43 to the
clag3.1-expressing 7C20 culture and achieved robust reverse
selection: the surviving parasites exhibited both low ISPA-28
affinity and a reversed clag3 expression profile (Figures 6J
and 6K). Thus, inhibitors can be used in purifying selections
of either clag3 gene. Because ISPA-28 affinity can be reduced
either through drift without selective pressure or by selection
for the alternate paralog with an inhibitor having reversed677, May 27, 2011 ª2011 Elsevier Inc. 671
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Figure 6. Relative Expression of clag3 Alleles Determines ISPA-28 Affinity
(A) Mean ± SEM ISPA-28 dose responses for indicated progeny (symbols) and the expected efficacy based on inheritance of the locus from Dd2 (solid line).
(B) Ethidium-stained gels showing relative expression of clag3 alleles in indicated lines. Amplicons represent full-length cDNA.
(C and D) Transport inhibition dose responses after in vitro selections with sorbitol and ISPA-28. Selection does not change HB30s dose response but improves
that of HB33rec and indicated progeny to levels matching Dd20s. Symbols represent mean ± SEM for indicated lines; solid lines represent parental phenotypes
from Figure 1E.
(E) Expression patterns for clag genes in indicated lines before and after in vitro selection, determined by quantitative RT-PCR.Mean ±SEMof replicates; see also
Table S4.
(F) clag3.1:clag3.2 expression ratio after selections of indicated lines, showing that lines isogenic with Dd2 at the clag3 locus are strongly purified, whereas HB3 is
not. Mean ± SEM values calculated from up to four RNA harvests each.
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specificity, these studies mitigate concerns about indirect
effects of exposure to sorbitol or individual inhibitors.clag3 Mutation in a Leupeptin-Resistant PSAC Mutant
A stable parasite mutant with altered PSAC selectivity, gating,
and pharmacology was recently generated by in vitro selection
of HB3 with leupeptin (Lisk et al., 2008). We sequenced clag3
genes from this mutant, HB3-leuR1, and identified a point muta-
tion within its clag3.2 gene that changes the conserved A1210 to
a threonine (Figure 7A and Figure S7A), consistent with a central
role of clag3 genes in solute uptake. HB3-leuR1 silences its
unmodified clag3.1 and preferentially expresses the mutated
clag3.2 (expression ratio of 19.2 ± 1.5, determined as in Fig-
ure 6F), as required for a direct effect on PSAC behavior. This
mutation is within a predicted transmembrane domain and
may directly account for the observed changes in channel gating
and selectivity. Because HB3-leuR1 may carry additional
genome-level changes, further studies will be needed to deter-
mine the precise role of the A1210T mutation in leupeptin
resistance.clag3 Products Are Exposed at the Host Erythrocyte
Surface
To directly contribute to PSAC activity, at least some of the clag3
product must associate with the host membrane, presumably as
an integral membrane protein. We therefore raised polyclonal
antibodies to a carboxy-terminal recombinant fragment
conserved between the two clag3 products. Confocal micros-
copy with this antibody confirmed reports localizing these
proteins to the host cytosol and possibly the erythrocyte
membrane aswell as within rhoptries of invasivemerozoites (Vin-
censini et al., 2008) (Figure S7B). To obtain more conclusive
evidence, we used immunoblotting to examine susceptibility of
these proteins to extracellular protease. Without protease treat-
ment, a single 160 kDa band was detected in whole-cell
lysates, consistent with the expected size of clag3 products (Fig-
ure 7B). Treatment with pronase E under conditions designed to
prevent digestion of intracellular proteins reduced the amount of
the full-length protein and revealed a 35 kDa hydrolysis frag-
ment. In contrast, amonoclonal antibody against KAHRP, a para-
site protein that interacts with the host membrane cytoskeleton
but is not exposed (Kilejian et al., 1991), confirmed that intracel-
lular proteins are resistant to hydrolysis under our conditions
(Figure 7C). As reported for another protease (Baumeister
et al., 2006), pronase E treatment significantly reduced PSAC-
mediated sorbitol uptake (Figure 7D); this effect was sensitive
to protease inhibitors, suggesting that proteolysis at one or
more exposed sites interferes with transport.
Ultracentrifugation of infected cell lysates revealed that the
clag3product is fullymembrane associated (Figure 7E); a fraction(G) Kinetics of decrease in ISPA-28 efficacy for HB33rec upon continuous in vitro
(H) Kinetics of decreasing expression of the chimeric clag3.2HB3-3.1Dd2 transgene
the expression ratio relative to the endogenous clag3.1.
(I) Structure of ISPA-43. See also Figure S6.
(J) Reversed selection using ISPA-43. 7C20 culture previously selected for clag
presence of ISPA-43. Graphic shows ISPA-28 dose response (circles, mean ± S
(K) qRT-PCR expression profile for 7C20 after reversed selection using ISPA-43.could, however, be liberated by treatment with Na2CO3, which
strips membranes of peripheral proteins (Fujiki et al., 1982).
Because this fraction was protease insensitive, it reflects an
intracellular pool of clag3 product loosely associated with
membranes. The C-terminal hydrolysis fragment was present
only in the carbonate-resistant insoluble fraction, indicating an
integral membrane protein.
Because our polyclonal antibodiesmight cross-react with clag
products from other chromosomes, we next examined protease
sensitivity in HB33rec, whose chimeric clag3 transgene encodes
a C-terminal FLAG tag. Anti-FLAG antibody recognized a single
integral membrane protein in HB33rec and no proteins from the
parental HB3 line, indicating specificity for the recombinant
gene product (Figure 7F). Treatment with pronase E prior to
cell lysis and fractionation revealed a hydrolysis fragment indis-
tinguishable from that seen with the antibody raised against the
native protein’s C terminus.DISCUSSION
We have used high-throughput screening to identify ISPA-28, an
inhibitor with remarkable specificity for solute uptake by erythro-
cytes infected with Dd2 parasites. Patch-clamp studies revealed
that this compound acts specifically on PSAC. Because its
activity is restricted to one parasite lineage (Figure S1), ISPA-
28 addresses previous concerns regarding inhibitor specificity
and implicates a central role for PSAC in anion and nutrient trans-
port at the host membrane.We then tracked inheritance of ISPA-
28 efficacy in the Dd23HB3genetic cross and identified a single
parasite genomic locus. Gene complementation, allelic ex-
change, in vitro selections using ISPA-28, and a point mutation
in a known PSAC mutant implicate two clag genes from this
locus.
A transport role for members of the clag gene family is unex-
pected because the encoded proteins already have proposed
roles unrelated to transport. The first clag gene was identified
via a chromosome 9 deletion event linked to loss of infected
erythrocyte binding to melanoma cells (Schmidt et al., 1982;
Day et al., 1993). clag9 is present in the deletion locus and
appears to function in infected cell cytoadherence to the endo-
thelial receptor CD36 (Trenholme et al., 2000). Other clag genes,
identified through the P. falciparum genome sequencing project,
were presumed to serve related functions. Proposals have
included infected cell binding to various endothelial receptors
(Holt et al., 1999), merozoite invasion of erythrocytes (Rungruang
et al., 2005; Kaneko, 2007), or as a chaperone for protein export
(Craig, 2000; Vincensini et al., 2008; Goel et al., 2010). The role
for clag3 products in solute transport requires a broader view
for functions of this gene family; this role is compatible with
two previous observations. First, isolated disruption of clag9culture after end of ISPA-28 selection. Mean ± SEM from up to five trials each.
in HB33rec after cessation of ISPA-28 selection, presented as mean ± SEM of
3.1 using ISPA-28 (panel C) was subjected to sorbitol synchronizations in the
EM) and that of the parental Dd2 (solid line).
Mean ± SEM of replicates.
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Figure 7. clag3 Mutant Analysis and Host
Membrane Localization
(A) Sequence chromatograms from wild-type HB3
and mutant HB3-leuR1 showing the point muta-
tion (red arrow) that changes A1210 to threonine.
(B) Immunoblot of total lysate from HB3-infected
cells without or with protease treatment of intact
cells. Blot was probed with a polyclonal antibody
to a recombinant clag3 fragment.
(C) Control immunoblot showing that the intracel-
lular parasite protein KAHRP is not hydrolyzed by
protease treatment.
(D) Osmotic lysis kinetics without or with protease
treatment, showing that PSAC activity is degraded
by pronase E. Addition of protease inhibitors
prevents loss of channel activity (pronase E + pi,
green trace).
(E) Immunoblot showing that the protein is
membrane associated and partially extractable
with carbonate treatment (CO3
=), and that the
protease hydrolysis fragment is an integral
membrane protein (membr).
(F) Immunoblot of carbonate-extracted mem-
branes from HB3 and HB33rec without or with
protease treatment as indicated. Blot was probed
with anti-FLAG tag antibody, which does not
recognize HB3 and is specific for the recombinant
clag3 product.
(G) Schematic shows twomodels for the role of the
clag3 product in PSAC formation. A pronase E
cleavage site, a known hypervariable domain, and
the site of the HB3-leuR1 mutation are indicated.
Our studies support an intracellular C terminus;
the transmembrane topology shown is speculative
and based on computational analysis. The green
box (right panel) represents additional parasite or
host protein(s) that may contribute to channel
activity.
See also Figure S7.abolishes melanoma cell binding (Trenholme et al., 2000), sug-
gesting that other clag products cannot compensate for loss
of that member. Second, mutually exclusive expression of
clag3.1 and clag3.2 despite constitutive expression of other
familymembers has been reported (Corte´s et al., 2007), suggest-
ing that clag3 products may serve roles requiring greater protec-
tion from immune challenge. Our transport-based in vitro selec-
tions confirm this atypical gene regulation: whereas purifying674 Cell 145, 665–677, May 27, 2011 ª2011 Elsevier Inc.selection for one or the other clag3 genes
was readily achieved, significant changes
in expression of other members were not
detected (Figure 6).
The encoded proteins share a con-
served a-helical CLAG domain also
present in RON2, a rhoptry neck protein
implicated in erythrocyte invasion (Ri-
chard et al., 2010; Anantharaman et al.,
2007). Whereas clag genes are present
only in plasmodia, RON2 is more widely
distributed in apicomplexan parasites
and appears to be the ancestral member(Figure S6A). Phylogenetic analysis suggests that after diver-
gence from RON2, clag genes underwent expansion and split
into two distinct groups early in the Plasmodium lineage. One
group, typified by clag9 in P. falciparum, contains a single
member in each plasmodium, whereas the second group has
from one to four members in each species. Interestingly, both
RON2 and the clag products are packaged into rhoptries, organ-
elles present in the extraerythrocytic merozoite (Kaneko et al.,
2001); they are then secreted into the host cell upon invasion
(Ling et al., 2004; Vincensini et al., 2008).
Recognizing that clag3 encodes an integral protein at the host
erythrocyte membrane, we envision two models for how the
protein may contribute to channel activity. In one, the clag3
product alone forms a novel microbial nutrient and ion channel
(Figure 7G, left diagram). In the other, the clag3 product interacts
with one or more other proteins to form functional PSAC (Fig-
ure 7G, right diagram). Multisubunit channels are well estab-
lishedwith individual components contributing to solute recogni-
tion and permeation, channel gating, inhibitor or ligand binding,
and/or other regulatory functions. If there are additional subunits,
they might be either parasite-encoded or resident host proteins;
the identities of the additional proteins as well as the roles served
by each would need to be determined.
Several findings are relevant to the discussion of these
models. First, clag genes are present in all plasmodial species
but absent from other apicomplexan genera, paralleling trans-
port studies that show PSAC activity in only plasmodia (Alkhalil
et al., 2007). Second, a role for clag3 product in pore formation
is suggested by the A1210T mutation in a leupeptin-resistant
channel mutant: point mutations in other ion channel genes often
yield altered gating and selectivity. Third, the extracellular loop
35 kDa from the protein’s C terminus, identified through protease
susceptibility studies, exhibits marked variability between
P. falciparum lines, presumably due to positive selection by
host immunity (Figure S6C) (Iriko et al., 2008). Because the
Dd2 clag3.1 gene carries a unique sequence here, this site
may define the ISPA-28 binding pocket. Although conventional
membrane-spanning regions are missing, the Phobius algorithm
detects two conserved hydrophobic segments with high proba-
bility of forming transmembrane domains (residues 1000–1062
and residues 1208–1231 in the clag3.1 product, Figure S7C).
These atypical transmembrane domains along with the lack of
homology to known ion channels may contribute to PSAC’s
unusual selectivity and conductance properties, as established
by functional studies (Ginsburg and Stein, 1988; Cohn et al.,
2003; Bokhari et al., 2008).
Our findings open several new directions for future research.
Most importantly, they permit molecular studies into the mecha-
nisms of PSAC-inhibitor interaction and the process of solute
recognition and permeation through this unusual channel. A
second direction will be to explore the trafficking of parasite-en-
coded channel components to the host membrane. Surprisingly,
the clag products are synthesized many hours before channel
activity is detectable. As described above, these proteins are
packaged into rhoptries, secreted into the host erythrocyte
upon invasion, and trafficked across the parasitophorous vacu-
olar membrane prior to reaching the host membrane. Why is this
circuitous route taken when there is a more direct mechanism
involving synthesis in the intracellular parasite and signal
sequence-mediated export (Boddey et al., 2010; Russo et al.,
2010)?
By providing a definitive protein target, our study will also
stimulate drug and vaccine development against PSAC (Pillai
et al., 2010). Should enthusiasm be tempered by the presence
of two paralogous genes, selection for diversity at exposed
sites, and variable inhibitor affinities for parasite isolates? Whilepolymorphic sites on the channel have permitted linkage anal-
ysis and gene identification, most of the coding region is highly
conserved in P. falciparum and other malaria parasites,
consistent with conserved selectivity and transport biophysics
in all infected cells (Lisk and Desai, 2005). Because most inhib-
itors do not appear to interact with polymorphic sites, targeting
critical conserved parts of the protein for drug development will
be facilitated by the high-throughput screening approaches
used here.
EXPERIMENTAL PROCEDURES
Osmotic Lysis Experiments and High-Throughput Inhibitor Screen
Infected cell osmotic lysis in permeant solutes was used to quantify solute
permeabilities and was performed as described (Wagner et al., 2003). Tropho-
zoite stage P. falciparum cultures were enriched using the Percoll-sorbitol
method, washed, and resuspended at 25C and 0.15% hematocrit in
280 mM sorbitol, 20 mM Na-HEPES, 0.1 mg/ml BSA (pH 7.4) with inhibitor
as indicated; uptake of proline, alanine, or phenyl-trimethylammonium chloride
(PhTMA-Cl) was similarly measured after iso-osmotic replacement for sorbitol.
Osmotic swelling and lysis were continuously tracked by recording transmit-
tance of 700 nm light through the cell suspension (DU640 spectrophotometer
with Peltier temperature control, Beckman Coulter). Recordings were normal-
ized to 100% osmotic lysis at the transmittance plateau. Inhibitor dose
responses were calculated by interpolation of the time required to reach frac-
tional lysis thresholds. Dose responses were fitted to the sum of two Langmuir
isotherms:
P= a=ð1+ ðx=bÞÞ+ ð1 aÞ=ð1+ ðx=cÞÞ (1)
where P represents the normalized solute permeability in the presence of
inhibitor at concentration x, and a, b, and c are constants.
High-throughput inhibitor screens using this transmittance assay were per-
formed as described (Pillai et al., 2010). Screens were performed identically
with HB3- and Dd2-infected cells at room temperature using a 50,000
compound library with >90% purity confirmed by NMR (ChemDiv). Individual
microplate wells contained single compounds at a 10 mM final concentration.
Each microplate also contained two types of controls. Thirty-two positive
control wells received PBS instead of sorbitol; erythrocytes in these wells do
not lyse because PSAC has low Na+ permeability. Thirty-two negative control
wells received sorbitol with DMSO but no test compound. Readings were
taken at multiple time points to permit estimation of inhibitor affinity in
a high-throughput format. The purity and molecular weight of ISPA-28 were
confirmed by mass spectrometry.
The activity of each screening compound was calculated from readings at
the 2 hr time point, according to:
%B= 100  Acpd  Aneg

Apos  Aneg

(2)
where %B is the normalized channel block and Acpd represents the absor-
bance from a test compound well. Aneg and Apos represent the mean absor-
bances of in-plate negative and positive control wells. %B is a quantitative
measure of inhibitor activity.
Inhibitors having significantly differing efficacies against uptake byHB3- and
Dd2-infected cells were selected using a weighted difference statistic (WDS),
determined from %B values at the 2 hr time point according to:
WDS= j%BHB3 %BDd2j=ð3  sposÞ (3)
where spos is the standard deviation of in-plate positive control wells. Isolate-
specific inhibitors have WDSR 1.0; larger values correspond to greater differ-
ences in efficacy against uptake by the two screened parasite lines. Analysis
and data mining of the screens were automated using locally developed
code (DIAdem 10.2 and DataFinder, National Instruments).Cell 145, 665–677, May 27, 2011 ª2011 Elsevier Inc. 675
Electrophysiology
Whole-cell and single-channel currents were recorded under voltage-clamp
conditions using previously described patch-clamp methods (Alkhalil et al.,
2004). Details are provided in the Extended Experimental Procedures.
Linkage Analysis to Map Inheritance of ISPA-28 Efficacy
We selected a distinct collection of 443 polymorphic microsatellite markers
that distinguish the Dd2 and HB3 parental lines. Five additional single-nucleo-
tide polymorphisms within the chromosome 3 locus were identified by DNA
sequencing and were used to genotype progeny clones. These genotype
data were used to search for single and interacting genetic loci associated
with ISPA-28 efficacy in the cross-progeny by performing QTL analysis with
R/qtl software as described (Broman et al., 2003; http://www.rqtl.org/).
Because P. falciparum asexual stages are haploid, the analysis was analogous
to that for recombinant inbred crosses. Significance thresholds at the p = 0.05
level were determined by permutation analysis. A secondary scan to search for
additional QTL was carried out by controlling for the primary chromosome 3
locus as described in the R/qtl software package.
DNA Transfection of Malaria Parasites
All plasmids were confirmed by restriction digestion and sequencing, propa-
gated in E. coli strain XL-10 gold (Strategene), and prepared with EndoFree
Plasmid Mega Kit (QIAGEN). Percoll-enriched trophozoites were mixed with
plasmid-loaded erythrocytes and allowed to grow for two cycles before appli-
cation of 5 nMWR99210. Transformed cells were typically detected by micro-
scopic examination within 3–8 weeks. Details are provided in the Extended
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and four tables and can be found with this article online at doi:10.1016/
j.cell.2011.04.022.
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